Angion Provides Corporate Update and Reports Full Year 2021 Financial Results
March 30, 2022 16:05 ET
|
Angion Biomedica Corp.
-- Enrollment continues in Phase 2 JUNIPER trial of ANG-3070 for the treatment of patients with primary proteinuric kidney diseases -- Ended the year with nearly $89M in cash and cash equivalents ...
Global Idiopathic Pulmonary Fibrosis Disease Treatment Markets, 2018-2019 & 2020-2024
September 08, 2021 03:58 ET
|
Research and Markets
Dublin, Sept. 08, 2021 (GLOBE NEWSWIRE) -- The "Idiopathic Pulmonary Fibrosis Disease Treatment: Global Markets" report has been added to ResearchAndMarkets.com's offering.The current report...
Idiopathic Pulmonary Fibrosis (IPF) Clinical Landscape Report 2021 with 10-Year Disease Incidence and Prevalence Forecasts
July 13, 2021 05:13 ET
|
Research and Markets
Dublin, July 13, 2021 (GLOBE NEWSWIRE) -- The "Market Spotlight: Idiopathic pulmonary fibrosis (IPF)" report has been added to ResearchAndMarkets.com's offering. This Market Spotlight report covers...
Coalition for Pulmonary Fibrosis to Cease Operations
November 19, 2015 10:25 ET
|
Coalition for Pulmonary Fibrosis (CPF)
CULVER CITY, Calif., Nov. 19, 2015 (GLOBE NEWSWIRE) -- "Never doubt that a small group of thoughtful, committed, citizens can change the world. Indeed, it is the only thing that ever has." -- Margaret...
MediciNova to Initiate Clinical Trial of MN-001 (tipelukast) in IPF
October 09, 2015 06:00 ET
|
MediciNova, Inc.
LA JOLLA, Calif., Oct. 09, 2015 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange...
SPORTS RADIO HOST, COMMERCIAL BANK VP, ST. JUDE, UTHSC DOCTORS, TEMPLE ISRAEL RABBI TO SPEAK AT BOTANIC GARDEN CEREMONY
July 16, 2015 14:29 ET
|
Coalition for Pulmonary Fibrosis (CPF)
MEMPHIS, Tenn., July 16, 2015 (GLOBE NEWSWIRE) -- A deadly lung disease most have never heard of is lurking in the community and threatening the lives of some well-known Memphians as it has claimed...
CPF Celebrates Historic Year of Progress in Pulmonary Fibrosis
December 30, 2014 14:05 ET
|
Coalition for Pulmonary Fibrosis (CPF)
CULVER CITY, Calif., Dec. 30, 2014 (GLOBE NEWSWIRE) -- The Coalition for Pulmonary Fibrosis (CPF) played an important role in much of the year's successes in Pulmonary Fibrosis (PF), helping to make...
CORRECTION - Two FDA Approvals on Same Day Renew Hope for Pulmonary Fibrosis Community
October 16, 2014 17:19 ET
|
Coalition for Pulmonary Fibrosis (CPF)
CULVER CITY, CALIF., Oct. 16, 2014 (GLOBE NEWSWIRE) -- In its press release dated October 16, 2014 at 10:46 AM EST with the headline "Two FDA Approvals on Same Day Renew Hope for Pulmonary Fibrosis...
Two FDA Approvals on Same Day Renew Hope for Pulmonary Fibrosis Community
October 16, 2014 10:46 ET
|
Coalition for Pulmonary Fibrosis (CPF)
CULVER CITY, CALIF., Oct. 16, 2014 (GLOBE NEWSWIRE) -- Patients, families and researchers alike have anticipated for months the U.S. Food and Drug Administration (FDA) decisions on two drugs for...
CPF Applauds Two FDA Approvals Announced Today for First Drugs for Idiopathic Pulmonary Fibrosis
October 15, 2014 18:02 ET
|
Coalition for Pulmonary Fibrosis (CPF)
CULVER CITY, CALIF., Oct. 15, 2014 (GLOBE NEWSWIRE) -- The Coalition for Pulmonary Fibrosis (CPF) applauds the two U.S. Food and Drug Administration (FDA) approvals announced today for Idiopathic...